FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Ohman

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Julia Karlsson; Lars Lind; Pär Hallberg; Karl Michaëlsson; Lisa Kurland; Thomas Kahan; Karin Malmqvist; K Peter Ohman; Fredrik Nyström; Håkan Melhus
Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension.
Pär Hallberg; Julia Karlsson; Lars Lind; Karl Michaëlsson; Lisa Kurland; Thomas Kahan; Karin Malmqvist; K Peter Ohman; Fredrik Nyström; Ulrika Liljedahl; Ann-Christine Syvänen; Håkan Melhus
Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
Pär Hallberg; Lars Lind; Katarina Billberger; Karl Michaelsson; Julia Karlsson; Lisa Kurland; Thomas Kahan; Karin Malmqvist; K Peter Ohman; Fredrik Nyström; Ulrika Liljedahl; Ann-Christine Syvänen; Håkan Melhus
Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Ohman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Julia Karlsson; Lars Lind; Pär Hallberg; Karl Michaëlsson; Lisa Kurland; Thomas Kahan; Karin Malmqvist; K Peter Ohman; Fredrik Nyström; Håkan Melhus
Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension.
Clinical cardiology 2004;27(6):347-50.
2004: Pär Hallberg; Julia Karlsson; Lars Lind; Karl Michaëlsson; Lisa Kurland; Thomas Kahan; Karin Malmqvist; K Peter Ohman; Fredrik Nyström; Ulrika Liljedahl; Ann-Christine Syvänen; Håkan Melhus
Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
Clinical cardiology 2004;27(5):287-90.
2004: Pär Hallberg; Lars Lind; Katarina Billberger; Karl Michaelsson; Julia Karlsson; Lisa Kurland; Thomas Kahan; Karin Malmqvist; K Peter Ohman; Fredrik Nyström; Ulrika Liljedahl; Ann-Christine Syvänen; Håkan Melhus
Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
Clinical cardiology 2004;27(3):169-73.
2003: Karin Malmqvist; K Peter Ohman; Lars Lind; Fredrik Nyström; Thomas Kahan
Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
Journal of cardiovascular pharmacology 2003;42(6):719-26.
2003: Pär Hallberg; Lars Lind; Karl Michaëlsson; Lisa Kurland; Thomas Kahan; Karin Malmqvist; K Peter Ohman; Fredrik Nyström; Ulrika Liljedahl; Ann-Christine Syvänen; Håkan Melhus
Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy.
BMC cardiovascular disorders 2003;3():11.
2003: Pär Hallberg; Lars Lind; Karl Michaëlsson; Julia Karlsson; Lisa Kurland; Thomas Kahan; Karin Malmqvist; K Peter Ohman; Fredrik Nyström; Håkan Melhus
B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
Journal of hypertension 2003;21(3):621-4.
2002: Karin Malmqvist; K Peter Ohman; Lars Lind; Fredrik Nyström; Thomas Kahan
Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin.
Journal of internal medicine 2002;252(5):430-9.
2002: Pär Hallberg; Julia Karlsson; Lisa Kurland; Lars Lind; Thomas Kahan; Karin Malmqvist; K Peter Ohman; Fredrik Nyström; Håkan Melhus
The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.
Journal of hypertension 2002;20(10):2089-93.
2002: Fredrik Nyström; Karin Malmqvist; K Peter Ohman; Thomas Kahan
Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study.
Journal of hypertension 2002;20(8):1527-33.
2001: Lisa Kurland; Håkan Melhus; Julia Karlsson; Thomas Kahan; Karin Malmqvist; K Peter Ohman; Fredrik Nyström; Anders Hägg; Lars Lind
Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients.
Journal of hypertension 2001;19(10):1783-7.
2001: Karin Malmqvist; Thomas Kahan; Magnus Edner; Claes Held; Anders Hägg; Lars Lind; Richard Müller-Brunotte; Fredrik Nyström; K Peter Ohman; M D Osbakken; J Ostergern
Regression of left ventricular hypertrophy in human hypertension with irbesartan.
Journal of hypertension 2001;19(6):1167-76.
1998: K Peter Ohman; BE Karlberg
Circulating plasma prekallikrein and tissue kallikrein in normotensive and hypertensive humans: effects of angiotensin II infusion.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1998;20(3):313-28.
1998: Fredrik Nyström; E Aardal; K Peter Ohman
A population-based study of the white-coat blood pressure effect: positive correlation with plasma cortisol.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1998;20(1):95-104.
1997: Fredrik Nyström; Bertil Ekman; M Osterlund; Torbjörn Lindström; K Peter Ohman; Hans J Arnqvist
Serum leptin concentrations in a normal population and in GH deficiency: negative correlation with testosterone in men and effects of GH treatment.
Clinical endocrinology 1997;47(2):191-8.
1997: K Peter Ohman
Circulating kallikreins in normotensive and hypertensive humans: effects of mineralocorticoid administration.
Blood pressure 1997;6(4):214-22.
1997: Fredrik Nyström; BE Karlberg; K Peter Ohman
Serum angiotensin-converting enzyme activity correlates positively with plasma angiotensin II: a population-based study of ambulatory blood pressure and the renin-angiotensin system.
Journal of human hypertension 1997;11(5):301-6.
1997: K Peter Ohman; BE Karlberg
Circulating kallikreins during sodium chloride infusion in normal and hypertensive humans.
Blood pressure 1997;6(3):154-60.
1996: Fredrik Nyström; P Nilsson; A G Olsson; BE Karlberg; K Peter Ohman
A population study of plasma neuropeptide Y: correlations with components of the metabolic syndrome.
Blood pressure 1996;5(6):349-53.
1996: Fredrik Nyström; O Malmström; BE Karlberg; K Peter Ohman
Twenty-four hour ambulatory blood pressure in the population.
Journal of internal medicine 1996;240(5):279-84.
1987: B E Karlberg; Torbjörn Lindström; U Rosenqvist; K Peter Ohman
Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension.
The American journal of cardiology 1987;59(10):104D-109D.